SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-003272
Filing Date
2024-02-13
Accepted
2024-02-13 20:22:01
Documents
2
Period of Report
2024-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6274
2 EX-24 DOCUMENT attachment1.htm EX-24 3367
  Complete submission text file 0001209191-24-003272.txt   11083
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address
Lee Gary K. (Reporting) CIK: 0001907345 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 24631387